Treatment of sarin exposure.
DeBalli
Peter
P
Cook
D Ryan
DR
D000732:Androstanols / Q000627:therapeutic use; D000931:Antidotes / Q000627:therapeutic use*; D002619:Chemical Warfare Agents / Q000506:poisoning*; D002800:Cholinesterase Inhibitors / Q000506:poisoning*; D006801:Humans; D007442:Intubation, Intratracheal; D009467:Neuromuscular Depolarizing Agents / Q000627:therapeutic use*; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D011041:Poisoning / Q000188:drug therapy; D000077123:Rocuronium; D012524:Sarin / Q000506:poisoning*; D013390:Succinylcholine / Q000627:therapeutic use*
D000732:Androstanols; D000931:Antidotes; D002619:Chemical Warfare Agents; D002800:Cholinesterase Inhibitors; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D018696:Neuroprotective Agents; D012524:Sarin; D013390:Succinylcholine; D000077123:Rocuronium